Elevated Short Interest in VNRX
VolitionRX Ltd (VNRX) is showing signs of a primed short squeeze setup. As of August 27, 2026, the borrow fee for the stock stands at 21.7%. Official data from the August 14, 2026 settlement shows short interest at 5.0% of shares outstanding (683.9K shares), an increase from 3.9% in the previous cycle.
Market Dynamics
The combination of rising short interest and a 21.7% borrow fee indicates that short sellers are becoming more active and finding it increasingly expensive to maintain positions. With a days-to-cover ratio of 1.0, any sudden influx of buying volume could force a rapid covering cycle.
Key Takeaways
- Borrow fee is currently 21.7%.
- Short interest rose to 5.0% of float.
- Squeeze setup is flagged as high due to borrow fee structure.
- Shares outstanding have decreased by 83% over the last two years.
The Bottom Line
VolitionRX is exhibiting classic signs of a squeeze-prone stock. The rising cost of borrowing combined with increasing short interest makes this a name to watch for potential volatility.
Signal data sourced from CurvedTrading. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.